Materials and Methods

Chemicals, solutions and study samples
Acetic acid (≥ 99 %), ammonium hydroxide (28% in water), creatinine (anhydrous), formic acid (≥ 95%), hydrochloric acid (~37%), picric acid (1% in water), sodium hydroxide (≥ 97%, pellets), 0.1% formic acid in water (LC-MS grade) and 0.1% formic acid in acetonitrile (LC-MS grade) were purchased from SigmaAldrich (München, Germany). Chloroform (picograde), ethyl acetate (optigrade), methanol (optigrade) and water (optigrade) were obtained from LGC Standards (Wesel, Germany). Tetranor PGE-M, 2,3-dinor-8-iso-PGF 2α , 8-iso-PGF 2α , 2,3-dinor-TXB 2 , 11-dehydro-TXB 2 , LTE 4 , 12(S)-HETE, D 6 -tetranor-PGE-M, D 4 -8-iso-PGF 2α , D 4 -11-dehydro-TXB 2 , D 5 -LTE 4 and D 8 -12(S)-HETE were purchased from Biomol (Hamburg, Germany) with purities higher than 97%. All substances were stored at -40 °C. Working solutions of the desired concentrations were prepared by dilution in methanol. Urine samples were obtained from a dietary controlled trial with healthy subjects, informed consent and approval from the ethics committee of the Bavarian State Board of Physicians was obtained.
Sample preparation
Unless otherwise indicated, aliquots of 3 ml urine were used for analysis. 20 µl of acetic acid and 30 µl of an IS-mixture, containing 6 ng D 6 -tetranor-PGE-M, 6 ng D 4 -8-iso-PGF 2α , 6 ng D 4 -11-dehydro-TXB 2 , 1.5 ng D 5 -LTE 4 , and 1.5 ng D 8 -12(S)-HETE, were added to each sample prior to extraction.
We applied a modified liquid-liquid extraction (LLE) technique described by Bligh & Dyer (28). Accordingly, 11.25 ml B&D solution (methanol:chloroform 2:1 v/v) was added to each sample. After mixing the components vigorously, the sample was left at room temperature for 1 hour. Next, 3.75 ml chloroform and 3.75 ml water was added, subsequently the sample was mixed for some seconds and centrifuged for 10 min at 2500 rpm. The recovered chloroform phase was evaporated to dryness in a SpeedVac centrifuge (Thermo Scientific, Dreieich, Germany). The residue was dissolved in 100 µl methanol.
For testing purposes, different solid phase extraction (SPE) approaches were performed. For C18 reversed-phase (RP) SPE a Bond Elut C18 (500 mg, 3cc) cartridge was used (Agilent, Waldbronn, Germany). The sorbent was rinsed with 5 ml methanol and 5 ml water. After applying the sample, the sorbent was rinsed again with 5 ml water. Washing was performed with 3 ml 5% methanol in water. After drying the sorbent under vacuum, the sample was eluted with 4 ml methanol and evaporated to dryness in a SpeedVac centrifuge. The residue was dissolved in 100 µl methanol.
For polymeric SPE (I), an Oasis ® HLB cartridge (500 mg, 6cc) was used (Waters, Eschborn, Germany), extraction was carried out as described by Neale and Dean (29). After rinsing the sorbent with 5 ml methanol, 5 ml acetonitrile and 5 ml water, the sample was applied. The sorbent was washed with 3 ml 5% acetonitrile in water. After drying the sorbent under vacuum, elution was performed with 4 ml acetonitrile. The sample was evaporated to dryness in a SpeedVac centrifuge and dissolved in 100 µl methanol.
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For polymeric SPE (II), a Strata X 33 u cartridge (200 mg, 6cc) was used (Phenomenex, Aschaffenburg, Germany), extraction was performed according to the protocol from Dumlao and colleges (30). After the sorbent was rinsed with 5 ml methanol and 5 ml water, the sample was loaded. Next, it was washed with 3 ml 10% methanol in water. After drying the sorbent under vacuum, elution was performed with 4 ml methanol. Finally, the sample was evaporated to dryness in a SpeedVac centrifuge and dissolved in 100 µl methanol.
For polymeric RP/weak anion exchange SPE, an Easy cartridge (200 mg, 6cc) was used (MachereyNagel, Düren, Germany), for polymeric RP/strong anion exchange SPE, an Oasis ® MAX cartridge (500 mg, 6cc) was used (Waters, Eschborn, Germany). Extraction was performed for both SPE cartridges as described by Dahl and colleges (31). The sorbents were rinsed with 5 ml methanol containing 2% formic acid and 5 ml water. After applying the sample, washing was performed with 5 ml water, 3 ml 25% methanol in water and 3 ml acetonitrile. Subsequently, the sorbent was dried under vacuum and elution was performed with 2 x 2 ml methanol. Finally, the sample was evaporated to dryness in a SpeedVac centrifuge and dissolved in 100 µl methanol.
UPLC-SRM/MS analysis
The analysis was carried out on a triple quadrupole mass spectrometer API 5000 (AB Sciex, Darmstadt, Germany) LC-MS/MS system, equipped with a 1200 series binary pump (G1312B), a degasser (G1379B) and a column oven (G1316B) (Agilent, Waldbronn, Germany) connected to an HTC Pal autosampler (CTC Analytics, Zwingen, Switzerland). A Turbo V ion spray source operating in negative electro spray ionization (ESI) mode was used for detection (AB Sciex, Darmstadt, Germany). High purity nitrogen was generated by a nitrogen generator NGM 22-LC/MS (cmc Instruments, Eschborn, Germany).
Chromatographic separation was performed on a Waters (Eschborn, Germany) Acquity ultra performance liquid chromatography (UPLC) BEH C18 column (2.1 x 50 mm) with a 1.7 µm particle size.
The column was maintained at 30°C and the injection volume was set to 5 µl. Eluent A consisted of 0.1% formic acid in water, eluent B was 0.1% formic acid in acetonitrile. Gradient elution was performed with 5% B for 1 min, a linear increase to 53% B until 9.5 min, a linear increase to 76% B until 11 min, a step to 100% B until 11.1 min, hold for 1 min at 100% B and re-equilibration from 12.1 min to 14 min with 5%
B. The flow rate was set to 600 µl/min. The turbo ion spray source settings were as follows: ion spray voltage = -4 kV, heater temperature = 600°C, source gas 1 = 20 psi, source gas 2 = 5 psi, CAD gas = 5 psi and curtain gas = 40 psi. Analytes were monitored in the multiple reaction monitoring (MRM) mode, the MS program was separated into 5 periods as shown in Table 1 . Quadrupoles were working at unit resolution.
Calibration and Quantification
Calibration was achieved by spiking 3 ml aliquots of urine with different levels of eicosanoid standards. A described in the sample preparation section. Calibration curves were calculated by linear regression without weighting. Data analysis was performed with Analyst software 1.5.1 (AB Sciex, Darmstadt, Germany).
Creatinine analysis
For urine flow normalization, creatinine was determined. 20 µl urine was diluted with 1 ml water. The sample was centrifuged at 600 rpm and the supernatant was transferred to a 96 well plate. After adding 200 µl reaction solution (0.25 M NaOH:0.1% picric acid v/v) the plate was incubated at 36°C for 45 min, subsequently absorption at 492 nm was analyzed with a Genios microplate reader (Tecan, Crailsheim, Germany). Each plate comprised a calibration set and solvent blanks.
Statistical analysis
The level of significance between the groups (smokers and nonsmokers) was assessed using an independent-samples Mann-Whitney U test.
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Results
Eicosanoid fragmentation
To analyze eicosanoids, we applied electro-spray ionization (ESI) in the negative ion mode and acquired product ion spectra. Although LTE 4 could also be ionized in the positive mode, the negative ion mode was for all other analytes more advantageous (data not shown). The obtained fragmentation patterns and proposed fragmentation pathways are shown in Figure 1 . All analytes displayed [M-H] -ions.
The most intensive product ion for tetranor PGE-M was m/z 309 resulting from loss of one water molecule ( Figure 1A ). 2,3-dinor-8-iso-PGF 2α showed primarily one product ion at m/z 237 due to loss of a C 5 side chain and water ( Figure 1B ). 8-iso-PGF 2α forms a prominent ion at m/z 193, obtained supposedly by a complex fragmentation due to break-up of the cyclopentane ring and dispatch of a C 9 side chain, water and 2 protons ( Figure 1C ). For 2,3-dinor-TXB 2 , the most prominent ion was at m/z 70, which might be a two times negatively charged product ion (m/z 140/2) generated through fracture of the tetrahydropyran ring and loss of 2 protons ( Figure 1D ). However, for quantification m/z 123 instead of m/z 70 was used, because the appropriate mass transition showed less matrix interferences (data not shown). 11-dehydro-TXB 2 displayed a product ion at m/z 305 that might result from loss of butane and water plus 2 protons ( Figure 1E ). LTE 4 showed an ion at m/z 333 being formed by fragmentation of the amino-carboxyl moiety from the sulphur atom and dispatch of water ( Figure 1F ). 12-HETE`s major product ion was at m/z 179 probably formed through loss of a C 9 side chain ( Figure 1G ), which is in agreement with previous studies (24). In conclusion, we could find mass transitions for all tested compounds suitable for development of a quantitative SRM/MS method, because collision induced dissociation (CID) produced characteristic product ions for all analytes (Table 1) .
Eicosanoid chromatography
A proper chromatographic separation is crucial for eicosanoid analysis, because these compounds often occur in isobaric forms. In addition, urine contains a lot of interfering matrix components leading to ion suppression and mis-quantification. Previous studies have shown that reversed-phase (RP) high performance liquid chromatography (HPLC) is an adequate technique for separation of most eicosanoid species (30, 32, 33). Based on these data, we established chromatographic separation using a C18 RP analytical column. In contrast to previously published methods, we chose a short UPLC column containing very small particles (50 x 2.1 mm; 1.7 µm) allowing shorter runtimes (14 min including reequilibration compared to >20 min (HPLC column; 100 x 3.0 mm; 3.5 µm)).
All peaks were nicely shaped, sharp and separated from interfering matrix components (Figure 2A -L).
We could also achieve a co-elution of analyte and internal standard (IS), except for 2,3-dinor-8-iso-PGF 2α and 2,3-dinor-TXB 2 (no stable isotope labelled substances available). This is important in order to compensate for matrix effects and varying ionization efficiencies during gradient elution. Gradient elution was performed with a mixture of acetonitrile and water including 0.1 % formic acid, which improved ionization efficiency (data not shown). Because quite a number of mass transitions are required and the peaks were sharp and narrow and therefore nicely separated, the MS program was split into five periods by guest, on November 9, 2017 www.jlr.org
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to gain more and shorter scan-cycles per peak: 0 -5.5 min (tetranor PGE-M), 5.5 -7.5 min (2,3-dinor-8-iso-PGF 2α ; 2,3-dinor-TXB 2 ), 7.5 -9.0 min (8-iso-PGF 2α ; 11-dehydro-TXB 2 ), 9.0 -11.0 min (LTE 4 ), 11.0 -14.0 min (12-HETE) ( Figure 2 ; Table 1 ).
Sample extraction and matrix effects
In order to extract all analytes of interest with one common sample preparation approach, different extraction procedures were tested. Several working groups have described sample preparation approaches with solid phase extraction (SPE) containing sorbents bound to carbon chain RP phases (24, 34, 35) or polymeric RP phases (29, 31, 36-39). Therefore, we tested sample preparation using C18
RP SPE and polymeric RP SPE. We also evaluated mixed-mode SPE containing polymeric RP phases combined with weak or strong anion exchange functions, because most compounds have a negative charge at basic pH. Tests were carried out by adding an eiconsanoid standard mixture to a human urine pool and comparing the obtained signal intensities and signal to noise (S/N) ratios (Table 2) .
We could extract all eicosanoid species (except for 12-HETE) with each tested SPE cartridge. For most eicosanoid species an extraction at acidic pH 4 led to improved results compared to pH 8. C18 RP SPE was ideal for LTE 4 and 12-HETE extraction, polymeric RP SPE was very well suited for 2,3-dinor-TXB 2 and 11-dehydro-TXB 2 extraction (acidic pH, S/N). Sample preparation with mixed mode SPE containing a strong anion exchange function worked very well for most analytes, it was optimal for extraction of both PGF 2α species and tetranor PGE-M (acidic pH, S/N). By contrast, mixed mode SPE containing a weak anion exchange function was not so ideal for eicosanoid extraction compared to all other tested SPEs.
Because of its easy practical viability and to save costs we thought that a liquid/liquid extraction (LLE) procedure using chloroform according to Bligh and Dyer typically used for polar lipids like glycerophospholipds might be a well suitable alternative to sample preparation with SPE (28, 40). To our knowledge, this has not been tested for urinary eicosanoid sample preparation so far. We found that LLE allowed extraction of all analytes, but the extraction efficiency depended on the pH of the urine matrix.
The number of the extracted species increased with decreasing urinary pH (optimum at pH 4) ( Table 2 ).
Although the signal intensities for some analytes were found to be higher when using SPE, over the complete range of analytes generally the best S/N ratios were achieved with LLE (optimal for tetranor PGE-M, 11-dehydro-TXB 2 and 12-HETE). Therefore, for our further investigations, samples were prepared with LLE after urine samples were acidified (pH 4).
Calibration and quantification
For quantification and in order to compensate for variations in sample preparation and ionization efficiency, stable isotope labelled eicosanoids were added as IS prior to extraction. Calibration lines were generated by adding different concentrations of eicosanoids to a human urine pool ( Table 3 ). The ratio between analyte and IS was used for quantification. For 2,3-dinor-8-iso-PGF 2α , the IS D 4 -8-iso-PGF 2α
and for 2,3-dinor-TXB 2 , the IS D 4 -11-dehydro-TXB 2 was used, since stable isotope labelled substances
were not available for these compounds. Evaluation of all possible analyte-IS pairs showed the best by guest, on November 9, 2017 www.jlr.org
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accuracies and precisions for these analyte-IS allocations. The obtained calibration curves were linear in the tested calibration range and the correlation coefficients (R 2 ) were > 0.99 for all analytes. We could achieve excellent limits of detection (LOD) and limits of quantification (LOQ) ( Table 3) . LOD was defined as a signal to noise ratio of three, the LOQ was calculated as the triple fold of the LOD.
Method validation and sample stability
Method accuracy was calculated by using three spiked urine samples covering the entire calibration range. Accuracies between 95 and 113% were found for all tested compounds (Table 4) . Precisions were determined in three un-spiked urine matrices at three different levels. Intra-and inter-day coefficients of variations (CVs) were below 12% for all analytes (Table 4 ). Recoveries were calculated as the difference between area ratios of pre-spiked samples (eicosanoid standards were added before LLE) and post-spiked samples (eicosanoid standards were added to the recovered chloroform phase). Internal standards were added before LLE to both samples. Observed recoveries ranged between 25 % (tetranor-PGE-M) and 100 % (11-dehydro TXB 2 ) ( Table 4 ). Matrix effects were investigated using three individual urine samples by comparing the peak areas between urine samples and controls (water) at two levels. As shown in Table 5 , the percentage of area ratios difference for three different urine matrices compared to non-matrix samples ranged from -13.9 % to 10.7 % demonstrating that no significant matrix effect was present.
Finally, sample stability was assessed (Table 6 ). For this purpose, urine aliquots were stored for 30 hours at room temperature before samples were extracted. All analytes were stable under these conditions, except for tetranor-PGE-M (percent change of levels: -19.5; -24.8 %), LTE 4 (-28.5 %; -13.4 %) and 12-HETE (-29.3 %; -29.4%). After going through six freeze/thaw (F/T) cycles, only tetranor PGE-M showed some instability (~-15 %). The post-preparation sample stability exhibited at least 14 days at 10°C in the autosampler.
Method application
To test the suitability of our method for human biomonitoring purposes, eicosanoid levels in 24h-urine samples from smokers (N = 30) and non-smoking controls (N = 30) were quantified. It is well known that nicotine enhances PGE 2 generation through activation of COX-2 and that cigarette smoking increases oxidative stress (27, 41). To compensate for inter-individual differences of urinary dilution, eicosanoid levels were normalized for creatinine.
We found that metabolite levels determined with our novel UPLC-SRM/MS method generally were in good agreement with concentration ranges determined by other groups (16, 24, 33, 34, 36, 42) . As shown in Table 7 , tetranor PGE-M, both PGF 2α metabolites and 2,3-dinor-TXB 2 levels were significantly elevated in urines of smokers. Mean tetranor PGE-M levels were 5.68 ng/mg crea in smokers compared to 2.78 ng/mg crea in controls (p<0.001). 2,3-Dinor-8-iso-PGF 2α levels were 2 times higher in smokers than in non-smokers (p<0.001). Generally, 2,3-dinor-8-iso-PGF 2α concentrations were about ten times higher than 8-iso-PGF 2α concentrations. The latter were also affected by cigarette smoking (about 1.4
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Discussion
To evaluate and understand the physiological effects of lipid mediators, it is important to assess endogenous compounds originating form different pathways instead of single metabolites. Even though our newly developed method comprises not all eicosanoid species present in human urine (for TXB 2 alone, more than 20 urinary species have been described (43)), it allows quantitative profiling metabolites of patho-physiological relevance. All chosen eicosanoid species were previously linked to diseases like CVD or various forms of cancer (1, 9).
A major challenge was to develop a sensitive and robust LC-SRM/MS multi-method, suitable for all compounds of interest having individual chemical properties. All metabolites were ionized applying ESI in the negative mode. CID produced compound specific product ions. Possible underlying chemical structures are shown in Figure 1 . However, whether these proposed structures are correct and the outlined detailed mechanisms of fragmentation have to be further elucidated. Murphy and colleges
proposed that the ion at m/z 305 (fragmentation of 11-dehydro-TXB 2 ) might be a conjugated triene (Figure 1 ), generated through loss of water and CO 2 , and subsequent attack of the anionic site formed at C-2 on the hydrogen at C-8 and rupture of the lactone ring ( Figure 1E ) (43). For 12-HETE the same group suggested that for the fragment at m/z 179, the negative charge is located at C-12 (alkoxide anion;
formed by charge migration) and not at the carboxyl moiety, as suggested Suzuki et al. (Figure 1G ) (24, 43).
Although we had to take several compromises for developing a multi-analyte method, such as the choice of the sample preparation procedure or the ionization mode, we could achieve an excellent sensitivity (Table 3 ). In fact, we achieved the lowest LODs and LOQs for these analytes described until now (24, 31, 34, 36, 42, 44). In our view, this might be primarily due to three reasons: (i) A very sensitive instrument was used for LC-SRM/MS analysis. (ii) Analyte separation was carried out on an UPLC column with a 1.7µm particle size, leading to sharper peaks and thus to improved S/N ratios. (iii) LLE has been applied for sample preparation. Thus, the appropriate mass transitions showed less matrix interferences. For tetranor PGE-M, 11-dehydro-TXB 2 and 12-HETE, the S/N ratios were superior upon sample work-up with SPE (Table 2) . For all other analytes, S/N was at least comparable to SPE prepared samples. Further advantages of the chosen sample preparation are shorter processing and handling times. This is especially important for tetranor-PGE-M, LTE 4 and 12-HETE, which showed a certain level of instability at room temperature ( Table 6 ).
The total running time for our LC-SRM/MS method is shorter than for many other eicosanoid multianalyte methods (14 min versus > 20 min) (36, 38, 44). Although we could achieve a good separation of all analytes, one should mention that the peak detected for 12-HETE ( Figure 1G ) is racemic 12-HETE. A separation of 12(R)-and 12(S)-HETE could only be achieved with chiral chromatograpy (runtimes from 10 to 60 minutes) (24, 45). The major isomer present in human urine might be 12(S)-HETE (24, 33).
Calibration was performed by adding stable isotope labelled eicosanoid species (Table 3) . When IS were available, maximum compensation for matrix effects and ionization response were achievable. This is of particular importance as we used gradient elution. To evaluate LC-SRM/MS method performance, by guest, on November 9, 2017 www.jlr.org Downloaded from validation according to the U.S. Food and Drug administration (FDA) guidelines was conducted (46). We could achieve excellent accuracies and precisions for all analyzed metabolites.
As a first application, we analyzed urinary eicosanoid levels of samples from smokers and non-smokers.
It is well known that cigarette smoking and nicotine lead to increased circulating pro-inflammatory endogenous agents including PGE 2 , TXA 2 and PGF 2 , promoting development and progression of cancer (such as lung, gastrointestinal and bladder) and CVD (27, 47, 48). The analyte levels were normalized to creatinine to correct for urine dilution. An advantage of creatinine is that its biological variation within a homogenous population is relatively small. However, dis-advantages are its dependence on factors like diet, physical activity, age or gender (49). Alternatives for creatinine as normalization parameter would be the urine volume or osmolality (50). We found significantly elevated levels of urinary PGE-M Displayed are mean signal intensities and S/N ratios of a urine pool spiked with 0 .5 ng/ml tetranor PGE-M, 1.0 ng/ml 2,3-dinor-8-iso-PGF 2α , 0.15 ng/ml 8-iso-PGF 2α , 2.0 ng/ml 2,3-dinor-TXB 2 , 1.0 ng/ml 11-dehydro-TXB 2 , 0.15 ng/ml LTE 4 and 0.15 ng/ml 12(S)-HETE. SPE cartridges and applied extraction protocols are described in the materials and methods section. S/N was calculated with the Analyst 1. Calibration lines were generated by plotting the ratios of the areas analyte/IS against the spiked concentrations (ng/ml). LOD, limit of detection; LOQ, limit of quantification.
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-25 - Table 4 TABLE 4: Accuracies, intra-day and inter-day precisions and recoveries Spiked (ng/ml urine) Accuracy (%) Concentration (ng/ml urine) Intra-day (n = 5) Inter-day (n = 6) Spiked (ng/ml urine) Recovery (%) (ng/ml ± SD) CV (%) (ng/ml ± SD) CV (%)
-26 - Displayed are the peak area ratios of spiked standards at two levels in urine samples and control and the percent difference compared to control. Anal., analyte; IS, internal standard; diff; difference; cont., control. Displayed are the mean levels normalized to creatinine, the level of significance has been carried out with MannWhitney U Test. Crea, creatinine. Sig., level of significance.
